AcuamarkDx
Developer of a cancer screening blood technology designed to detect cancer markers at early stages. The company's technology integrates a suite of novel, multiplexed assays that test for several level...
Valuation
$85M
Market implied
Share Price
N/A
Total Raised
$25M
Last Round
N/A